Boehringer Ingelheim’s Metacam 20 has obtained approval in Canada for use in cattle to reduce pain associated with abdominal surgery, such as caesarean section.
The marketing authorization was granted based on recent research studies that show how cows’ behaviour is influenced by being treated with Metacam 20 immediately prior to abdominal surgery.
Previous Canadian research had shown similar benefits from administering a single dose of Metacam 20 before performing abdominal surgery.
Metacam is a non-steroidal anti-inflammatory drug of the oxicam class and is proven effective during various veterinary procedures across a range of species.
Comments